This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In the last three years alone, there have been over 633,000 patents filed and granted in the pharmaceutical industry, according to GlobalData’s report on Key innovation: Leading companies in nanoparticles for drugdelivery. Bristol-Myers Squibb is the leading patent filer in nanoparticles for drugdelivery.
Genentech’s ocular implant drugdeliverysystem for treatment of macular degeneration has received approval from the US Food and Drug Administration (FDA). Susvimo delivers ranibizumab via a port deliverysystem into a surgically placed implant in the eye, allowing for continuous delivery of the drug.
Biologics constitute a majority of the top selling drugs and represent one of the fastest growing segments of the overall pharmaceutical industry. In fact, the share of biologics in the overall pharmaceutical contract manufacturing market has increased from 16% in 2006 to over 25% in 2017.
Stakeholders Involved in intranasal therapeutics and drugdelivery domain. Most of the drugs (55%) are small molecules. Millions of dollars are being invested in funding the initiatives of various players engaged in the intranasal therapeutics and drugdelivery domain. Roots Analysis Report. Web: [link].
$158 Billion DrugDeliverySystems (DDS) Markets – Global Forecast to 2027 – Necessity of DrugDeliverySystems for Enhancing Therapeutic Efficiency and Safety Profile of Drugs – ResearchAndMarkets.com $158 Billion DrugDeliverySystems (DDS) Markets – Global Forecast to … Continue reading →
2020 Insights on the Global Markets and Technologies for Advanced DrugDeliverySystems – ResearchAndMarkets.com 2020 Insights on the Global Markets and Technologies for Advanced DrugDeliverySystems – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Global Markets and Technologies for Advanced DrugDelivery … (..)
Global Biotechnology, Drug Development and DrugDeliverySystems Nanoparticles Markets, 2019-2020 & 2025 – ResearchAndMarkets.com Global Biotechnology, Drug Development and DrugDeliverySystems Nanoparticles Markets, 2019-2020 & 2025 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Nanoparticles in Biotechnology, (..)
Global Microneedle DrugDeliverySystemsMarket (2021 to 2027) – Featuring Zosano Pharma, Raphas and Endoderma Among Others – ResearchAndMarkets.com Global Microneedle DrugDeliverySystemsMarket (2021 to 2027) – Featuring Zosano Pharma, Raphas and Endoderma Among Others – ResearchAndMarkets.com … Continue reading → (..)
Global Microneedle DrugDeliverySystemsMarket Report 2021: COVID-19 Impact Analysis, Growth and Changes to 2030 – ResearchAndMarkets.com Global Microneedle DrugDeliverySystemsMarket Report 2021: COVID-19 Impact Analysis, Growth and Changes to 2030 – ResearchAndMarkets.com DUBLIN–(BUSINESS WIRE)–The “Microneedle Drug (..)
Global Inhaled and Intranasal Products 2020-2030: Contract Service Providers Market – Focus on Drugs and DrugDeliverySystems – ResearchAndMarkets.com Global Inhaled and Intranasal Products 2020-2030: Contract Service Providers Market – Focus on Drugs and DrugDeliverySystems – ResearchAndMarkets.com … Continue reading (..)
Global Transdermal DrugDeliverySystemsMarket Research Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 & 2021-2026 – ResearchAndMarkets.com Global Transdermal DrugDeliverySystemsMarket Research Report 2021: Industry Trends, Share, Size, Growth, Opportunity and Forecasts, 2015-2020 … Continue (..)
Hence, a precision therapy or we can say a target therapy (involving intracellular drugdelivery) is much needed to all the patients suffering from cancer. Here is how the intracellular drugdelivery comes into action for majority of the fatal diseases that requires target therapy. The answer is yes.
Contract marketing companies support pharmaceutical companies in creating, improving, and maintaining their brand, as well as reducing risk, and ensuring better product placement in the market. Identifying the top commercial dose (non-sterile) companies in contract marketing.
Over the last two decades, the pharmaceutical industry has observed a paradigm shift from conventional drugdelivery strategies to the long-acting drugdelivery (LADD) of products to treat several disease indications, such as ophthalmic disorders, oncological disorders, neurological disorders and infectious diseases.
When it comes to vaccines and other high-value biologics, it is essential that effective formulations go hand in hand with safe delivery. To boost the profitability of the drug at a later stage in its lifecycle, manufacturers may then consider changing the presentation to prefilled syringes. Lowering extractables levels .
In order to promote the use of exosomes in various therapeutic applications including targeted drugdelivery vehicles, engineered exosomes and many more, there are a number of companies that offer services related to the isolation, purification, characterization or quantification of exosomes. Want additional details on the pipeline?
However, several drugdelivery devices that enable patients to self-administer their respective medications are now available. Subcutaneous biologics – current market landscape. Subcutaneous drugdeliverysystems – the helping hand for patients. Of these, 50 players have approved subcutaneous biologics.
In addition, NLCs offer benefits such as high drug loading capacity, improved drug retention and avoidance of drug expulsion. Advantages of Lipid Nanoparticle LNPs are gaining significant attention of formulation scientists in drugdelivery due to the various advantages offered by them.
XTALKS WEBINAR: DrugDelivery — Addressing Global Regulatory Challenges in Co-Packaged, On-Body Systems Live and On-Demand: Thursday, June 15, 2023, at 10am EDT (4pm CEST/EU-Central) Register for this free webinar to learn about on-body drugdeliverysystems and addressing their complex global regulatory requirements.
Nano-based deliverysystems are on the rise, as they enable manufacturers to deliver therapeutic agents to specific targeted tissue in a more controlled manner. Data indicates that the global nanopharmaceutical drugsmarket size reached USD 53.85 Billion in 2021 and is expected to reach USD 102.4 Billion in 2030.
Outsourcing offers several benefits to the developers including cost saving opportunities, increased operational efficiencies, expedited time-to-market, access to advanced capabilities and technologies, validated quality control setup, flexibility, risk sharing and, in several cases, regulatory support. Our Social Media Platform. Web: [link].
However, it is important to highlight that there are still several challenges which need to be addressed in order to develop biologic drugs capable of effectively being administered via the oral route without undergoing significant losses in specificity and / or bioavailability. Oral Protein / Peptide-based Drugs. Web: [link].
Recent years started witnessing the emergence of novel treatment approaches that have been keeping the Retinal vein occlusion market in a hyped-up state. Looking at the potential of the pipeline therapies they hold once approved, pharmaceutical companies are charting out a seemingly exciting course in the market.
To learn more, please click New Frontiers Cancer Therapy market report. Types of Molecules and Regions Worldwide Overall, the growth is anticipated to be spread across multiple type of molecules and different geographical regions. For any queries / suggestions, please do not hesitate to contact us at sales@rootsanalysis.com.
XTALKS WEBINAR: ISO 11608: Best Practices to De-Risk & Shorten Time to Market for Wearable Injectors. Register for this free webinar to learn the best practices to successfully incorporate 2022 ISO 11608 methodology to mitigate risk and accelerate time to market in combination product development.
Container Closure Integrity Testing Services Market. You may also be interested in the following titles: Live Biotherapeutic Products and Microbiome Manufacturing Marke t Next Generation Complement Therapeutics Market Intranasal Therapeutics and DrugDeliverySystemsMarket . Our Social Media Platform.
Driven by lucrative investments, extensive R&D efforts and contributions from various big pharma players, the myeloid cell targeting therapeutics market is expected to grow at a steady pace. Myeloid Cells Targeting Therapeutics Market. Roots Analysis – MYELOID CELL TARGETING THERAPEUTICS: BUDDING THERAPY AGAINST CANCER.
By charting new waters and creating uncontested market spaces, companies can differentiate themselves and unlock unprecedented growth opportunities. In this blog post, I’ll explore how pharma / biotech companies can leverage the blue ocean and red ocean strategy to make waves in the market.
Given the evident benefits of biologics over small molecule drugs (including high efficacy, target specificity and favorable safety profiles), the biopharmaceutical market is poised to witness continued and consistent growth over the next several years. Future Evolution of Biopharmaceutical Excipient Manufacturing Market.
Next Generation Complement Therapeutics – Current Market Landscape. The market is characterized by a mix of well-established and small firms. The pipeline features more than 190 next generation complement therapeutics that are either marketed / are currently being evaluated across different phases of development. Web: [link].
One of the biggest challenges with developing therapies to treat CNS disorders is the delivery of systemically administered investigational products (IPs) to the brain, which is limited by the blood-brain barrier. Some methods of direct CNS administration include intrathecal, intraparenchymal and intracerebroventricular (ICV) delivery.
Role of nanoparticles has been well established across various markets, such as healthcare, paint, consumer products ( including sunscreens, cosmetics ), aerospace and glass industries. In fact, the market opportunity is expected to be boosted further as an impact of COVID-19. Nanoparticles Contract Manufacturing. Web: [link].
Device innovations, connected delivery and regulatory guidance for advanced parenteral systems. The global pre-filled syringes market was valued at $1139.6 Engage in panel discussions with industry leaders to navigate the accelerating digital health landscape for combination products and drugdeliverysystems.
Further, the biggest challenge in this domain is the purification which involve the use of hazardous solvents / materials and stability of drug products ( thereby, requiring specialized facilities and cold chain transportation).
However, for such a burdensome and highly prevalent sight-threatening eye disorder, the Retinal vein occlusion treatment market has no curative option to offer. Retinal vein occlusion drugmarket. The present market lacks an effective treatment to unblock retinal veins.
AI is able to mine records, design treatment studies, find out targets of drugdelivery in a way more drastic manner than a human can. Nanodevices are used to improve medical imaging and some nanoparticle-based drugdeliverysystems are currently being used in research and studies. Nanotechnology.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content